Thorsten Schulte
Overview
Explore the profile of Thorsten Schulte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grundmann K, Laubis-Herrmann U, Dressler D, Vollmer-Haase J, Bauer P, Stuhrmann M, et al.
J Neurol
. 2004 Oct;
251(10):1232-4.
PMID: 15503103
Spinocerebellar ataxia type 17 (SCA17) is a dominant progressive neurodegenerative disorder, caused by a triplet repeat expansion within the TATA-binding protein. As well as ataxia and dementia, Parkinsonism and dystonia...
2.
Grundmann K, Laubis-Herrmann U, Dressler D, Vollmer-Haase J, Bauer P, Stuhrmann M, et al.
Mov Disord
. 2004 Sep;
19(11):1294-7.
PMID: 15390016
Primary dystonias represent a clinically and genetically heterogeneous group of movement disorders. Mutations in the epsilon-sarcoglycan (SGCE) gene have been found recently to cause myoclonus-dystonia (MD). Considerable clinical variation of...
3.
Schols L, Bauer P, Schmidt T, Schulte T, Riess O
Lancet Neurol
. 2004 Apr;
3(5):291-304.
PMID: 15099544
Autosomal dominant cerebellar ataxias are hereditary neurodegenerative disorders that are known as spinocerebellar ataxias (SCA) in genetic nomenclature. In the pregenomic era, ataxias were some of the most poorly understood...
4.
Muller T, Voss B, Hellwig K, Stein F, Schulte T, Przuntek H
CNS Drugs
. 2004 Jan;
18(2):105-11.
PMID: 14728057
Objective: In some countries, such as Germany, there has been a move towards the treatment of patients with Parkinson's disease in specialised inpatient units. However, data on patient outcome and...
5.
Kruger R, Fischer C, Schulte T, Strauss K, Muller T, Woitalla D, et al.
Neurosci Lett
. 2003 Oct;
351(2):125-9.
PMID: 14583397
Neurofilament M, a major component of Lewy bodies, represents an interesting candidate in the pathogenesis of Parkinson's disease (PD). We performed detailed mutation analyses of the NF-M gene in 322...
6.
Grundmann K, Laubis-Herrmann U, Bauer I, Dressler D, Vollmer-Haase J, Bauer P, et al.
Arch Neurol
. 2003 Sep;
60(9):1266-70.
PMID: 12975293
Background: Dystonia is a clinically and genetically heterogeneous movement disorder characterized by sustained muscle contractions affecting one or more sites of the body, frequently causing twisting and repetitive movements or...
7.
Schols L, Bauer I, Zuhlke C, Schulte T, Kolmel C, Burk K, et al.
Ann Neurol
. 2003 Jul;
54(1):110-5.
PMID: 12838526
To evaluate the significance of expanded CTG repeats at the SCA8 locus, we analyzed the allele distribution in 1,262 German ataxia patients. We found intermediate and expanded CTG repeats with...
8.
Muller T, Kuhn W, Schulte T, Przuntek H
Neurosci Lett
. 2003 Mar;
339(1):25-8.
PMID: 12618292
Intravenous application of amantadine sulphate induces a rapid improvement of motor symptoms in Parkinson's disease (PD), but there are no trials on the efficacy of this compound on bradykinesia, rigidity...
9.
Schulte T, Schols L, Muller T, Woitalla D, Berger K, Kruger R
Neurosci Lett
. 2002 Jun;
326(1):70-2.
PMID: 12052541
Several lines of evidence indicate that immune mechanisms are involved in the pathogenesis of neurodegenerative disorders. Activated immunocompetent cells and inflammatory cytokines are present in affected brain regions in patients...